Does Gabapentin Cause Memory Loss? What the Evidence Shows
Gabapentin can cause cognitive slowing while you take it: drowsiness, reduced attention and slower processing speed are documented in controlled studies, and patients describe it as brain fog. Whether long-term use raises the risk of dementia is a different and harder question. A 2025 analysis of more than 52,000 adults linked six or more gabapentin prescriptions to 29 percent more dementia diagnoses and 85 percent more mild cognitive impairment diagnoses within ten years. That study is observational: it cannot prove the drug caused the diagnoses, and its own coverage in the medical press says so. What the evidence clearly supports is narrower: gabapentin affects thinking in some people, older adults are more sensitive, and no one should stop it on their own. This page lays out the documented effects, the new study with its limits, and the right conversation to have with your prescriber.
Written and fact-checked by RecallPath Editorial Team. Last updated: . About our editorial process.
- Documented cognitive effects: in a randomized crossover study, a single 600 mg dose reduced attention, vigilance, wakefulness and processing speed in healthy adults (Frontiers in Pharmacology review, 2022). These effects run through sedation and are usually dose-related.
- The 2025 study: 52,828 adults with chronic low back pain; six or more gabapentin prescriptions were followed by 29% more dementia and 85% more MCI diagnoses over ten years. Observational. The authors and the medical press warn against causal conclusions.
- Higher-risk groups in that study: adults 35 to 49 showed the largest associations (more than double the dementia diagnosis rate), with a dose-response pattern across 6 to 12-plus prescriptions.
- Not a classic anticholinergic: clinical references rate gabapentinoids as moderate-to-low anticholinergic activity. The memory mechanism here is CNS depression, not the anticholinergic pathway behind drugs like older antihistamines.
- FDA warning (2019): serious breathing problems when gabapentin is combined with opioids or other CNS depressants, especially with lung conditions or in older adults.
What gabapentin is and why so many people take it
Gabapentin is a prescription drug approved for two uses: partial seizures and nerve pain after shingles (postherpetic neuralgia). In real-world practice, most prescriptions are off-label: other neuropathic pain conditions, migraines, restless legs and sometimes anxiety or sleep. It was the fifth most dispensed drug in U.S. retail pharmacies in 2024, according to CDC figures published in the Annals of Internal Medicine. Millions of adults, many of them over 50, take it daily and for years. That scale is exactly why cognitive questions about it matter, and why the answers have to stay precise.
The documented cognitive effects
Attention and vigilance
The best-controlled evidence: a randomized crossover trial found a single 600 mg dose impaired sustained attention and vigilance in healthy adults, as reviewed in Frontiers in Pharmacology (2022). This is the mechanism behind patients’ reports of losing the thread mid-conversation or rereading the same paragraph.
Processing and motor speed
Reaction time and information processing slowed on the same controlled testing. The clinical translation: feeling a step behind in discussions, or that decisions take longer than they used to.
Sedation as the root
The cognitive effects track with drowsiness. That is why they are typically dose-related, strongest after dose increases or when combined with other sedatives, and why they tend to improve when the dose comes down. Older adults clear the drug more slowly and feel these effects at lower doses.
What patients call gabapentin brain fog is, in most cases, this sedative package wearing a different name: slowed recall, word-finding pauses, foggy mornings. These effects are real, they are documented, and in the controlled data they are temporary and reversible. That is a different claim from permanent memory loss, and the two should never be conflated.
The 2025 dementia-link study, honestly
What the analysis found
Published in Regional Anesthesia & Pain Medicine, the study used a large U.S. health records database (TriNetX) to compare 26,414 adults with chronic low back pain who had six or more gabapentin prescriptions against an equal matched group, followed for ten years (2004-2024).
Why caution is the correct response: this is an observational database study. It cannot separate the drug from the conditions it treats: chronic pain itself is linked to cognitive decline, as are poor sleep, reduced activity, depression and the other medications these patients take. The authors say no causal conclusions can be drawn. Medical coverage of the study, including outlets that reported the risks, carried the same caveat, and some analyses suggest parts of the 2025 adverse-event signal may have been overestimated. What the study justifies is monitoring and a conversation. It does not justify stopping a prescribed drug.
What gabapentin is not
Precision matters here, because two different drug problems get mixed up in internet discussions. The drugs with the strongest evidence for harming memory through long-term use are the high-anticholinergic medications: older bladder drugs, some antihistamines, tricyclic antidepressants. Clinical anticholinergic-burden references rate gabapentinoids as moderate-to-low on that scale. Gabapentin’s cognitive signature is different: immediate, sedative, dose-related, and usually reversible. Lumping it into the anticholinergic-dementia story overstates one risk and understates the other conversation, which is about sedation, falls, and interactions.
Who should pay closer attention
- Adults over 60: slower clearance, higher sensitivity to sedation, and cognitive complaints are more likely to be medication-related and more likely to be mistaken for something worse.
- Anyone combining gabapentin with opioids, sleep medications or alcohol: the FDA’s 2019 warning covers serious breathing problems with these combinations; the sedation and cognitive load stack too.
- People on high doses or long-term courses: the dose-response pattern in the 2025 study is one more reason periodic re-evaluation of dose is standard practice, not alarmism.
- Anyone who noticed thinking change after starting or increasing the dose: that timing is clinical gold. Write it down with dates.
If you are concerned: the right sequence
Do not stop gabapentin abruptly. Sudden discontinuation after regular use can cause withdrawal symptoms, and in people taking it for seizures, stopping can trigger seizures. The correct sequence is a conversation, not a unilateral decision. Tell your prescriber what you noticed, when it started relative to dose changes, and how it affects your day. Options typically include dose adjustment, switching to an alternative for the underlying condition, or a structured taper if discontinuation makes sense. If the memory concern is new and significant, ask for the standard reversible-cause workup too: B12 and thyroid blood tests, a medication review, and an honest look at sleep. Our B12 guide covers the most common hidden mimic, and our memory supplements hub maps what has trial data once the medical questions are settled.
Frequently Asked Questions
Does gabapentin cause memory loss?
It can cause cognitive slowing while you take it: drowsiness, reduced attention and slower processing speed are documented in controlled studies, driven by sedation. Whether long-term use causes permanent memory loss or dementia is unproven. A large 2025 observational study linked multiple prescriptions to more dementia diagnoses, but it cannot establish causation. Report thinking changes to your prescriber rather than stopping the drug yourself.
Is gabapentin brain fog permanent?
In the controlled evidence, the sedative cognitive effects are temporary and reverse when the dose is reduced or the drug is stopped, typically over days to weeks. Persistent cognitive complaints deserve a full workup anyway, because other causes, from B12 deficiency to poor sleep, often coexist and are independently treatable.
Does gabapentin increase dementia risk?
Unknown. The 2025 TriNetX analysis found higher dementia and mild cognitive impairment diagnoses among long-term users, with a dose-response pattern, but as an observational study it cannot separate the drug from chronic pain, sleep disruption and other medications. The study’s authors and medical press coverage both warn against causal conclusions. It supports monitoring, not stopping.
Is gabapentin an anticholinergic drug?
Not in the classic sense. Clinical anticholinergic-burden references rate gabapentinoids as moderate-to-low anticholinergic activity. Its memory effects run through CNS sedation rather than the anticholinergic pathway associated with the strongest dementia signal in medication research. The sedative interaction risk with opioids, sleep drugs and alcohol is the more concrete concern.
Can I stop taking gabapentin suddenly?
No. Abrupt discontinuation after regular use can cause withdrawal symptoms including anxiety, insomnia and nausea, and in people taking it for seizures it can provoke seizure activity. If cognitive side effects are the concern, tell your prescriber: dose adjustment, a switch, or a supervised taper are the safe paths.
What should I ask my doctor about gabapentin and memory?
Three questions carry most of the weight: is my dose the lowest effective one; is the timing of my thinking changes consistent with dose changes; and could something else, like B12, thyroid or sleep, be contributing. Bring a short dated log of symptoms. That log turns a vague worry into an actionable clinical picture.
Are pregabalin and gabapentin the same for memory?
They are sister drugs with similar mechanisms, and pregabalin carries the same class-level profile of sedation and cognitive slowing in susceptible users. Neither has proof of causing permanent memory loss, and both share the sedative-interaction cautions. Any switch between them is a prescriber decision based on the condition being treated.
Sources and References
- Cognitive and psychomotor effects of gabapentinoids – Frontiers in Pharmacology, 2022
- Chronic gabapentin use linked to dementia and MCI diagnoses – BMJ Group, Regional Anesthesia & Pain Medicine, 2025
- Gabapentinoids may carry dementia risk, but questions remain – MedPage Today
- Anticholinergic medicines and cognitive impairment – bpacnz clinical reference
- FDA warning: serious breathing problems with gabapentin and pregabalin, 2019
Need help choosing?
RecallPath does not sell supplements. We publish facts for readers over 40.
Email us